![]() |
Early peek at Remdesivir data shows promise against Covid 19
Excerpt:
Last month, President Trump touted the potential for remdesivir — as he has for many still-unproven treatments — and said it “seems to have a very good result.” :popcorn: Gilead data suggests coronavirus patients are responding to treatment |
Quote:
|
Remdesivir has shown past efficacy against other severe corona viruses, MERS and SARS in animal models, not human testing. So the theoretical hope is that it will also work against this corona virus.
There are ongoing controlled studies testing remdesivir both in the US and elsewhere. I am hopeful this will be an effective therapy. The one downside is that this drug is under patent and price will be, I suspect, substantial. It also is an IV drug, not oral. |
What is used to help hospital patients with the flu? Still more people die and are hospitalized for the flu.
|
Quote:
|
Quote:
Covid seems to damage, often fatally damage, the lungs without any contribution from secondary bacterial pneumonia. Lessons learned from use of antiviral and antibacterial medications in treating influenza have not helped in treatment of Covid. Covid is not flu. |
Currently, in the US
Death rate for the flu is about .1% For covid, about 2-4% |
Quote:
|
Quote:
|
Quote:
|
Quote:
|
Quote:
|
Quote:
|
Quote:
|
FROM MY FRIEND THE DOCTOR:
Is remdesivir the COVID miracle we've been waiting for? Gilead certainly hopes you think it is Gregory Katz Apr 17 The medical world was buzzing after data on the drug remdesivir was published in the New England Journal of Medicine showing that 68% of COVID patients treated with remdesivir improved. Now we’re seeing reports from all over the place - CNN, the New York Times, Axios - touting the “promise” and “encouraging signs” of this medication in preliminary data from another clinical trial. Gilead, the company that makes this drug, has unsurprisingly seen a bump in its stock after these reports. What is remdesivir? Remdesivir is a broad spectrum antiviral drug that works by blocking viral replication. In an isolated lab setting, it has demonstrated effects against multiple different virus families, including filoviruses like Ebola and corona viruses like SARS, MERS, and SARS-CoV-2 (the virus responsible for COVID-19). Remdesivir seems to reduce lung injury in both mice and macaques infected with MERS. It also has effectiveness in test tubes against SARS-CoV-2. The medical term for the effects that it has blocking the virus in a lab setting is “in vitro,” which basically means that it happens outside of a living organism. Lots of compounds have in vitro effects that don’t pan out when we study them in actual humans with actual diseases. This is why we do randomized clinical trials in medicine - because what makes biologic sense based on our predicted models doesn’t always pan out when we put it to the test in real life. All models are wrong, but some models are useful. Indeed, when remdesivir was studied in real Ebola patients, it was actually removed from the trial protocol during an interim analysis because it was less effective than the other treatments being tested. Tell me about the recent trial showing improvement in 68% of remdesivir patients The COVID patients treated with remdesivir in the recently published NEJM trial were patients approved for use of the drug by Gilead on something called a “compassionate use” basis. This was a group of 53 patients with an average age of 62. They were required to have a need for oxygen support, and they couldn’t have any evidence of kidney or liver failure. In other words, sick enough to need hospitalization and respiratory support, but fairly young and not having failure of any other organ system. About 25% of them had diabetes and about 17% had hypertension. Important to note that in this study, remdesivir was not compared to a placebo. This is a report of what happened to the patients who received remdesivir, NOT a comparison of this treatment to any others. And keep in mind that all patients needed to be approved by Gilead before receiving the drug. The investigators found that 36 of the 53 patients (68%) had improvement in oxygen needs while 15% got worse in this area. There was a lot of attention paid to the fact that the sickest patients (30 who were intubated and 4 who were on ECMO) had decent outcomes, with 17 of the intubated patients having breathing tubes removed and 3 of the ECMO patients stopped receiving it. But hold your horses: the fact that there’s no comparison in this trial means that we have no idea whether patients got better because of remdesivir or in spite of it. What about this new report? According to STAT news, where this update was first reported, they’re seeing great effects from remdesivir given to 113 patients with severe disease. However, buried deep in the article there’s evidence that you should take these results with a huge grain of salt. Take a look at this quote from the lead investigator at University of Chicago, where these patients were treated: “It’s always hard,” she said, because the severe trial doesn’t include a placebo group for comparison. “But certainly when we start [the] drug, we see fever curves falling,” she said. “Fever is now not a requirement for people to go on trial, we do see when patients do come in with high fevers, they do [reduce] quite quickly. We have seen people come off ventilators a day after starting therapy. So, in that realm, overall our patients have done very well.” Not to sound like a broken record, but until there is a randomized trial where remdesivir is being compared to a placebo, we just don’t know whether patients got better because of remdesivir or in spite of remdesivir. So what will the randomized trial tell us? Gilead is currently enrolling 2,400 patients in a randomized, placebo controlled trial. After the initial paper came out showing results from patients receiving remdesivir, there were some changes to the trial protocol, which a cynic would interpret as standard pharma funny business. The bottom line is that we don’t know anything until the trial results come out. Remdesivir might work, but it also might make things worse. When it was properly studied in Ebola, results weren’t particularly encouraging. When hydroxychloroquine was studied compared to placebo in COVID-19, it seemed to have no benefit but had increased side effects. We do trials to test hypotheses, and right now all we have about remdesivir are hypotheses. I don’t think I’m ready to recommend using your stimulus check on Gilead stock until we get actual data from a true randomized trial. If you liked this post from Gregory Katz's email newsletter, why not share it? |
Quote:
Also someone on this thread said that the seasonal flu shot was not a vaccine. That is incorrect; Key Facts About Seasonal Flu Vaccine | CDC Also someone said that they don't appreciate the posts from the M.D.s who live here. I certainly do and I know that many do as well. There is a lot of misinformation circling about. A lot of it is simply because we have not had enough time and statistics to really evaluate the hard data that changes every day. The world has only been following this completely new and dangerous virus since late November when the outbreak and deaths were first reported in Wuhan in China. |
Quote:
|
Well Said!!!😊
Good advice. :coolsmiley:
|
when you're trying to solve a complex challenge you don't take anything off the table until it is proven to not be a viable approach, or a viable solution has been found and is being successfully implemented
Thankfully our leaders stepped up and are leading.... no leader in history has ever made everyone happy 100% of the time |
Quote:
|
Quote:
|
Quote:
Quote:
CASE DATA FOR SUMTER as of 9 AM 4/18 Total Cases: 120 [these are test positive cases] Deaths: 11 11/120 = .092 times 100 = 9.2% Demographics of Cases Age: Age Range: 18 to 92 Median Age: 68 |
Next
Quote:
Please look things up before you post. Certainty is not the same as accuracy. |
Next
Quote:
The word vaccine does however relate to the history of smallpox. Edward Jenner noticed that milkmaids who contracted cowpox seemed resistant to getting smallpox. He theorized that the milder cowpox illness was protective. He tested taking fluid from cowpox blisters and inoculating people with that fluid. In Latin cow is "vacca" The word vaccine is now used medically and commonly for all the shots and oral products used. |
Quote:
Maybe he should say that there are no drugs that offer hope and we're all gonna die? |
Quote:
|
Prof Simon Maxwell, Professor of Clinical Pharmacology and Prescribing, University of Edinburgh, said:
“The research is interesting but doesn’t prove anything at this point: the data are from a small and uncontrolled study. Remdesivir is currently being assessed in large scale clinical studies, which will be critical in determining whether it is a safe and effective treatment for COVID-19. This is not least because there were some adverse events (60%) reported in the current study, some of them serious (23%), including multiple organ failure, septic shock, acute kidney injury, and hypotension.” |
Quote:
|
Quote:
|
Quote:
Besides, DR Fauci is not infallible and has made several blunderous statements. “it’s a very, very low risk to the United States. … It isn’t something the American public needs to worry about or be frightened about. Because we have ways of preparing and screening of people coming in [from China] " “in all the history of respiratory viruses, asymptomatic transmission has never been the driver of outbreaks. An epidemic is not driven by asymptomatic carriers.” |
Quote:
|
You are exactly right! Politicians, and that includes the president, are not equipped or educated to make decisions on when we will be safe again from this pandemic. We should not be in such a rush to re-open anything. We all miss going to the squares, out to restaurants and going to a movie, but people shouldn’t be such complaining babies about it. And the argument I keep hearing about your freedom being trampled on is just ridiculous! Would you rather be dead? Would you rather expose people to your selfishness and stupidity? We will all be ok if we listen to medical professionals and stop crying about it and learn how to cope.
|
All times are GMT -5. The time now is 05:22 PM. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2025, vBulletin Solutions Inc.
Search Engine Optimisation provided by
DragonByte SEO v2.0.32 (Pro) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.